Active Cancer Biomarkers Grants

PI Namesort descending Organization - Company Title Major Program / Research Group FOA
Singamaneni, Srikanth Washington University METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION RFA-CA-18-004: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research
Skates, Steven J Massachusetts General Hospital Proteomic, Genomic, and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery Early Detection Research Network, EDRN Biomarker Development Lab PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Skubitz, Amy Patrice University Of Minnesota A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection PA-20-185: NIH Research Project Grant
Slager, Susan L. Mayo Clinic Rochester The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) PA-20-185: NIH Research Project Grant
Sowers, Lawrence C University Of Texas Med Br Galveston Cytosine Deamination Adducts and Cancer Etiology PAR-18-704: Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention
Spector, Logan G. University Of Minnesota Determining the cell of origin in Ewing sarcoma through genomic analysis PAR-18-020: NCI Clinical and Translational Exploratory/Developmental Studies
Storz, Peter Mayo Clinic Jacksonville Smoking carcinogen-induced initiation of pancreatic cancer PAR-19-356: NCI Clinical and Translational Exploratory/Developmental Studies
Stowell, Sean R Brigham And Women'S Hospital Integrating microbial glycan arrays with genomic sequences to study host microbe interactions RFA-RM-18-036: Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions
Sutcliffe, Julie L University Of California At Davis Peptide-based targeted molecular imaging for early detection in pancreatic cancer Pancreatic Cancer Detection Consortium PAR-15-289: The Pancreatic Cancer Detection Consortium
Tanasova, Marina Michigan Technological University Exploiting cellular discrimination through GLUTs with small-molecule GLUT-targeting probes PA-18-504: Academic Research Enhancement Award
Tempst, Paul Sloan-Kettering Inst Can Research Protein and proteolytic activity biomarkers of early stage pancreatic cancer PA-16-160: NIH Research Project Grant
Thakur, Mathew Laxman Thomas Jefferson University Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer Consortium for Imaging and Biomarkers PAR-19-264: Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer
Turesky, Robert J. University Of Minnesota DNA adductomics of the urinary system PAR-15-308: Innovative Basic Research on Adducts in Cancer Risk Identification and Prevention
Umbricht, Christopher B Johns Hopkins University Discovery and validation of early molecular breast cancer risk markers in benign breast disease PA-16-160: NIH Research Project Grant
Vigneron, Daniel B University Of California, San Francisco Hyperpolarized C-13 MRI for Early Detection of Aggressive Prostate Cancer in Active Surveillance Patients Consortium for Imaging and Biomarkers PAR-16-089: Imaging and Biomarkers for Early Cancer Detection

Pages